TY - JOUR T1 - Glycaemic control was not affected by self-monitoring of blood glucose in type 2 diabetes JF - Evidence Based Medicine JO - Evid Based Med SP - 170 LP - 171 DO - 10.1136/ebm.13.6.170 VL - 13 IS - 6 A2 - , Y1 - 2008/12/01 UR - http://ebm.bmj.com/content/13/6/170.abstract N2 - M J O’KaneDr M J O’Kane, Altnagelvin Hospital, Londonderry, Northern Ireland; maurice.okane@esterntrust.hscni.netDesign:randomised controlled trial (Efficacy of Self Monitoring On glycaemic control in Newly diagnosed type 2 diabetes [ESMON]).Allocation concealment:unclear allocation concealment.*Blinding:blinded (laboratory staff).*Setting:outpatient hospital diabetes clinics in Altnagelvin, Belfast City, Causeway, and Ulster, Northern Ireland.Patients:184 patients <70 years of age (mean age 59 y, 60% men) with newly diagnosed type 2 diabetes. Exclusion criteria were secondary diabetes, previous self-monitoring of blood glucose (SMBG), use of insulin, major illness in the past 6 months, chronic kidney or liver disease, and alcohol misuse.Intervention:SMBG (n = 96) or no monitoring (n = 88). The SMBG group made 4 fasting and 4 postprandial capillary blood glucose measurements per week and were provided dietary and exercise suggestions for high readings. All patients attended a structured education programme.Outcomes:changes in haemoglobin (Hb) A1c concentrations, scores on psychological indices (depression, anxiety, treatment satisfaction, and attitude; measured on a 100-point scale), body mass index (BMI), rates of hypoglycaemia, and use of oral hypoglycaemic drugs.Follow-up period:1 year.Patient follow-up:98% (intention-to-treat analysis).Patients in the SMBG group scored 6% higher on the depression subscale than did the no-monitoring group (p = 0.01). Groups did not differ for changes in HbA1c concentration (table), anxiety, … ER -